VC

Viswanath Chebrol

Active Director Designated Partner DIN 01556254
DIN 01556254 First appointment Jul 2007 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 11 historical roles
Total affiliations 15 Since Jul 2007
Shareholding value •••• Premium profile
Directorship timeline
First appointment 13 Jul 2007
Active appointments 5
Total timeline records 15

Viswanath Chebrol (DIN 01556254) has 15 recorded board appointments in Indian companies, the first from July 2007, of which 5 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2007
Gcbc Vaccines Private Limited Director · 2024 - 2026
Current
Current
Gland Chemicals Pvt Ltd Director · 2022 - 2026
Current
Parami Advisory Partners Llp Designated Partner · 2022 - 2026
Current
Easystich Needles Private Limited Additional Director · 2009 - 2026
Current
Symbiotec Pharmalab Limited Additional Director · 2018 - 2019
Previous
Sadguru Healthcare Services Private Limited Nominee Director · 2017 - 2022
Previous
Biorad Medisys Private Limited Director · 2016 - 2023
Previous
Sandor Medicaids Private Limited Director · 2016 - 2024
Previous
Relisys Medical Devices Limited Nominee Director · 2014 - 2023
Previous
Neuland Health Sciences Private Limited Director · 2013 - 2017
Previous
Neuland Pharma Research Private Limited Alternate Director · 2012 - 2017
Previous
Fermenta Biotech Limited Director · 2011 - 2017
Previous
Healthium Medtech Limited Director · 2010 - 2012
Previous
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available